• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例多发性内分泌腺瘤病2A家族病例:一个家族三代人的形态学至基因改变及外显率情况

A Familial Case of Multiple Endocrine Neoplasia 2A: From Morphology to Genetic Alterations Penetration in Three Generations of a Family.

作者信息

Chen Lan, Zhang Jing-Xin, Liu Dong-Ge, Liu Hong-Gang

机构信息

Pathology Department, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.

Pathology Department, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology, Beijing 100730, China.

出版信息

Diagnostics (Basel). 2023 Mar 2;13(5):955. doi: 10.3390/diagnostics13050955.

DOI:10.3390/diagnostics13050955
PMID:36900098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10000614/
Abstract

This paper illustrates a rare syndrome of multiple endocrine neoplasia type 2A (MEN2A) in a family of three generations. In our case, the father, son and one daughter developed phaeochromocytoma (PHEO) and medullary thyroid carcinoma (MTC) over a period of 35 years. Because of the metachronous onset of the disease and lack of digital medical records in the past, the syndrome was not found until a recent fine needle aspiration of an MTC-metastasized lymph node from the son. All resected tumors from the family members were then reviewed and supplemented with immunohistochemical studies, previously wrong diagnoses were then corrected. Further molecular study of targeted sequencing also revealed a RET germline mutation (C634G) in the family tree including the three members with onset of the disease and one granddaughter who had no disease at the time of testing. Despite the syndrome being well-known, it may still be misdiagnosed because of its rarity and long disease onset. A few lessons can be learned from this unique case. Successful diagnosis requires high suspicion and surveillance and a tri-level methodology including a careful review of family history, pathology and genetic counselling.

摘要

本文阐述了一个三代家族中的罕见的2A型多发性内分泌腺瘤病(MEN2A)综合征病例。在我们的病例中,父亲、儿子和一个女儿在35年的时间里先后患上了嗜铬细胞瘤(PHEO)和甲状腺髓样癌(MTC)。由于疾病的异时性发病以及过去缺乏数字化医疗记录,该综合征直到最近对儿子的一个MTC转移淋巴结进行细针穿刺活检才被发现。随后对家族成员所有切除的肿瘤进行了复查,并补充了免疫组化研究,纠正了之前的错误诊断。针对测序的进一步分子研究还揭示了该家族谱系中存在RET基因种系突变(C634G),包括三名发病成员和一名检测时未患病的孙女。尽管该综合征广为人知,但由于其罕见性和发病时间长,仍可能被误诊。从这个独特的病例中可以吸取一些经验教训。成功的诊断需要高度的怀疑和监测,以及包括仔细回顾家族病史、病理学和遗传咨询在内的三级方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/10000614/8939cb545aac/diagnostics-13-00955-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/10000614/028be1892399/diagnostics-13-00955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/10000614/4689e1ed8af9/diagnostics-13-00955-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/10000614/ceffc96ae9eb/diagnostics-13-00955-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/10000614/8939cb545aac/diagnostics-13-00955-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/10000614/028be1892399/diagnostics-13-00955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/10000614/4689e1ed8af9/diagnostics-13-00955-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/10000614/ceffc96ae9eb/diagnostics-13-00955-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d08/10000614/8939cb545aac/diagnostics-13-00955-g004.jpg

相似文献

1
A Familial Case of Multiple Endocrine Neoplasia 2A: From Morphology to Genetic Alterations Penetration in Three Generations of a Family.一例多发性内分泌腺瘤病2A家族病例:一个家族三代人的形态学至基因改变及外显率情况
Diagnostics (Basel). 2023 Mar 2;13(5):955. doi: 10.3390/diagnostics13050955.
2
[Clinical and genetic analysis of seven Chinese pedigrees affected with multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis].7个伴有皮肤苔藓样淀粉样变的2A型多发性内分泌肿瘤中国家系的临床及遗传学分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2022 Sep 10;39(9):938-943. doi: 10.3760/cma.j.cn511374-20210727-00627.
3
A Homozygous RET K666N Genotype With an MEN2A Phenotype.携带有 MEN2A 表型的 RET K666N 纯合子基因型。
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1269-1272. doi: 10.1210/jc.2017-02402.
4
Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families.RET 筛查对 2A 型多发性内分泌肿瘤管理的影响:三个家族的 10 年经验和随访。
Endocr Metab Immune Disord Drug Targets. 2022;22(3):339-347. doi: 10.2174/2214083203666210826094602.
5
Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.中国通过靶向测序鉴定的种系 RET 变异体谱及相关多发性内分泌肿瘤 2 型易感性。
BMC Cancer. 2021 Apr 7;21(1):369. doi: 10.1186/s12885-021-08116-9.
6
Elevated basal serum levels of calcitonin and simultaneous surgery of MEN2A-specific tumors.降钙素基础血清水平升高和 MEN2A 特异性肿瘤的同时手术。
Neoplasma. 2021 Sep;68(5):1098-1106. doi: 10.4149/neo_2021_210330N419. Epub 2021 Jun 23.
7
RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma family.外显子组测序在中国 2A 型多发性内分泌肿瘤/家族性髓样甲状腺癌家系中发现的 RET 种系突变。
PLoS One. 2011;6(5):e20353. doi: 10.1371/journal.pone.0020353. Epub 2011 May 31.
8
Long-term Clinicopathological Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by C634R Gene Mutation.由C634R基因突变引起的2A型多发性内分泌腺瘤病家族的长期临床病理特征
Indian J Nucl Med. 2020 Jan-Mar;35(1):48-53. doi: 10.4103/ijnm.IJNM_168_19. Epub 2019 Dec 31.
9
Multiple endocrine neoplasia type 2A. Study of a family.2A型多发性内分泌腺瘤病。一个家族的研究。
Rev Port Cardiol. 2000 Jan;19(1):11-31.
10
Late-Onset Medullary Thyroid Cancer in a Patient with a Germline Codon C634R Mutation.一名携带种系密码子C634R突变患者的迟发性甲状腺髓样癌
Diagnostics (Basel). 2021 Aug 11;11(8):1448. doi: 10.3390/diagnostics11081448.

引用本文的文献

1
mutation in -induced multiple endocrine neoplasia type 2A: A case report.突变诱导的2A型多发性内分泌腺瘤病:一例报告。
World J Clin Cases. 2024 May 26;12(15):2627-2635. doi: 10.12998/wjcc.v12.i15.2627.

本文引用的文献

1
FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with Gene Mutations or Fusions.FDA 批准概要:塞普替尼用于治疗具有基因突变或融合的肺癌和甲状腺癌。
Clin Cancer Res. 2021 Apr 15;27(8):2130-2135. doi: 10.1158/1078-0432.CCR-20-3558. Epub 2020 Nov 25.
2
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.美国甲状腺协会修订的甲状腺髓样癌管理指南。
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
3
Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases.
神经营养因子受体RET:结构、细胞生物学及遗传性疾病
Ann Med. 2007;39(8):572-80. doi: 10.1080/07853890701646256.
4
Hereditary hormone excess: genes, molecular pathways, and syndromes.遗传性激素过多:基因、分子途径与综合征
Endocr Rev. 2005 Aug;26(5):615-61. doi: 10.1210/er.2003-0037. Epub 2005 Jan 4.
5
Minireview: RET: normal and abnormal functions.小型综述:RET:正常与异常功能
Endocrinology. 2004 Dec;145(12):5448-51. doi: 10.1210/en.2004-0922. Epub 2004 Aug 26.